After decades of prohibition, several states in the country have been decriminalizing cannabis and setting up legal markets. Encouraged by research and anecdotal evidence about marijuana’s numerous potential medical benefits, thousands of people have been turning to the controversial plant to cure what ails them, often with encouraging results. Cannabis has been found to be effective against chronic pain, inflammation, neurological and mental disorders as well as sleep disorders.
A new study from Negrev, Israel, has come to a conclusion that could have major implications for millions of Americans. Noticing an increase in the number of older people who were using cannabis and hemp extract cannabidiol (“CBD”), researchers from Ben-Gurion University launched the study to see how cannabis use affected those individuals. After studying a group of older people, the researchers found that regular cannabis use lowers diastolic and systolic blood pressure for people aged 60 and older who had hypertension.
The study had 26 participants who were diagnosed with the condition and had a prescription for cannabis. The researchers observed and studied the participants for three months, performing a variety of tests such as blood pressure monitoring, anthropometric measurements, ECG and blood tests. They recorded a five-point drop in systolic pressure and a 4.5 point-drop in diastolic pressure; systolic pressure is the higher number in the blood pressure reading while diastolic pressure is the lower number.
The team from Ben-Gurion University also noted that the number of “normal dippers,” meaning individuals whose blood pressure dips at night, increased from 27.3% at the start of the study to 45.5% after three months. They believe this drop in blood pressure may be due to cannabis’ ability to relieve pain. Whatever the reason, the results of this study are important for the more than 100 million Americans living with hypertension.
Hypertension is a major cause of heart disease, with an estimated 500,000 deaths per year being hypertension related, the U.S. Centers for Disease Control and Prevention reports. If researchers can find enough evidence to prove that cannabis and CBD can alleviate the condition, it would be a reprieve for millions of Americans who are constantly at risk of developing fatal conditions because of hypertension.
Similar studies are being conducted across the globe as the world realizes marijuana’s immense medical potential. However, the American Heart Association notes that progress in the United States has been held back because federal law classifies cannabis as a controlled substance, hindering proper research.
Lots of companies are aware of the medical potential of different cannabis compounds. This may be why Green Hygienics Holdings Inc. (OTCQB: GRYN) specializes in manufacturing bioactive cannabinoids that meet the requirements of the pharmaceutical industry.
NOTE TO INVESTORS: The latest news and updates relating to Green Hygienics Holdings Inc. (OTCQB: GRYN) are available in the company’s newsroom at http://cnw.fm/GRYN
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
